Evidence map›Paper›PMID 41534004›Full record

ArticleJCO clinical cancer informatics2026

Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based Models.

Emily C Liang, Yein Jeon, Yang Qiao, Xiancheng Wu, Jennifer J Huang, Andrew J Portuguese, Ryan Basom, Aiko Torkelson, Delaney Kirchmeier, Kristina Braathen and 7 more

Abstract read
In one paragraph

Article in JCO clinical cancer informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Emily C LiangFred Hutch Cancer Center, Seattle, WA.ORCID 0000-0001-5790-4770
Yein JeonFred Hutch Cancer Center, Seattle, WA.ORCID 0000-0002-7382-5906
Yang QiaoFred Hutch Cancer Center, Seattle, WA.ORCID 0000-0002-6534-5304
Xiancheng WuFred Hutch Cancer Center, Seattle, WA.ORCID 0009-0009-5830-1475
Jennifer J HuangFred Hutch Cancer Center, Seattle, WA.ORCID 0000-0003-0863-9389
Andrew J PortugueseFred Hutch Cancer Center, Seattle, WA.ORCID 0000-0003-1010-4578
Ryan BasomFred Hutch Cancer Center, Seattle, WA.
Aiko TorkelsonFred Hutch Cancer Center, Seattle, WA.ORCID 0009-0003-0144-4906
Delaney KirchmeierFred Hutch Cancer Center, Seattle, WA.ORCID 0009-0008-5593-3314
Kristina BraathenFred Hutch Cancer Center, Seattle, WA.ORCID 0009-0003-5362-1556
Andrew J CowanFred Hutch Cancer Center, Seattle, WA.ORCID 0000-0002-1880-7094
Mazyar ShadmanFred Hutch Cancer Center, Seattle, WA.ORCID 0000-0002-3365-6562
Alexandre V HirayamaFred Hutch Cancer Center, Seattle, WA.ORCID 0000-0001-7980-3882
Brian G TillFred Hutch Cancer Center, Seattle, WA.
Erik L KimbleFred Hutch Cancer Center, Seattle, WA.ORCID 0000-0002-1885-1773
Qian WuFred Hutch Cancer Center, Seattle, WA.ORCID 0000-0002-2292-4816
Jordan GauthierFred Hutch Cancer Center, Seattle, WA.ORCID 0000-0002-5769-8409

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
TRAINING IN CANCER BIOLOGY &TRANSPLANTATIONT32CA009515 · NCI · UNIVERSITY OF WASHINGTON · PI NANCY ELLEN DAVIDSON, Effie W Petersdorf · 1985 to 2026
$16.2M
RESEARCH TRAINING IN HEMATOLOGYT32HL007093 · NHLBI · UNIVERSITY OF WASHINGTON · PI Janis L Abkowitz · 1985 to 2026
$13.9M
Medical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
$6.6M
NCI NIH HHS P30 CA015704NCI NIH HHS T32 CA009515NHLBI NIH HHS T32 HL007093NIGMS NIH HHS T32 GM145449
6 · The paper itself

Abstract

purposeImmune effector cell-associated hematotoxicity (ICAHT) is a major cause of nonrelapse mortality after chimeric antigen receptor (CAR) T-cell therapy. We hypothesized that unsupervised time-series clustering could better identify archetypal patterns of early hematotoxicity compared to the early ICAHT (eICAHT) grading system.

methodsWe applied unsupervised k-means time-series clustering based on Euclidean distances to longitudinal absolute neutrophil count (ANC) data from days +0 through +30 post-CAR T-cell infusion in 691 patients treated at our center (training set: n = 483, 70%; test set: n = 208, 30%).

resultsWithin our training set, we identified an optimal cluster solution based on four ANC recovery clusters, which were labeled as very good, good, poor, and very poor. We trained a random forest (RF) model including the top five most important features (day +3, +4, +5, +26, and +27 ANC values) to predict the cluster assignments. Within our test set, we applied the RF model to predict cluster assignments. Compared with the eICAHT criteria, the RF-predicted clusters were more compact and better separated (Dunn index: 0.078

conclusionUnsupervised time-series clustering identified distinct and clinically relevant patterns of hematotoxicity after CAR T-cell therapy. We trained and tested an RF model that accurately predicted cluster assignments using only five features. Predictions can be generated using our online web application.

Indexed as

NeoplasmsAlgorithmsCluster AnalysisClustering AlgorithmsHumansNeutrophilsRandom ForestReceptors, Chimeric AntigenReceptors, Chimeric Antigen

Identifiers

PMID41534004
PMCPMC12810859

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.